Submit ICO / Airdrop ★ Get Promotion
ProjectsDeFiAirdropsSTOsPromotionMarks newsWatchlist ()
0
Eventa

Eventa

TBA
8,825 Views
Visit Website
Last screenshot taken on
16 Mar 2020 .
Add to Watchlist
Eventa is the first 0% commissions blockchain-based ticketing solution for the long-tail events market. Eventa empowers event organizers to self-manage their ticketing with a P2P blockchain system. This creates a better system for event organizers and event attendees challenging the market dominance of traditional long-tail ticketing platforms such as Eventbrite. Event organizers will not rely on platforms taking their fees, but they use Eventa technology to issue tickets on the blockchain via a set of open source smart contract templates.
Other
7.6
TOTAL SCORE
6.2
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Dates: TBA
Token info
Ticker: EVTA
Platform: Ethereum
Token Type: ERC20
Financial
ICO Price: 1 EVTA = 0.005 USD
Accepting: ETH
Soft cap: 2,500,000 USD
Hard cap: 31,500,000 USD
Social media
Twitter
Telegram
Github
Medium
July 2015
Ticketing affiliation business model and first partnerships with Ticketing platforms: Eventim, TicketMaster, Viagogo, Seatwave among others.<br />
January 2017
Launching EventAds – Advertising platform for organizers<br />
June 2017
Eventa reaches 400K Monthly users<br />
February 2018
Eventa opens in the US (700K Monthly Users)<br />
June 2018
Private Sale Launch<br />
September 2018
Pre-ICO Launch<br />
Q3 2018
Public main crowdsale and protocol development underway<br />
Q4 2018
Alfa version Open Protocol, Partnering with blockchain events to test the system<br />
Q1 2019
Open Protocol beta Release; New version of the portal for event discovery; Organizer app beta release for IOS and Android<br />
Q2 2019
Protocol and Platform stable versions; Campaigns to boost product adoption; advanced smart ticketing contracts; Aliation API and widgets; On-boarding third-parties apps for event organizers<br />
Screenshots taken on 16 Jan 2019
Andrea Zanda
CEO & Founder
Participates in a number of projects
Gianluca Vinci
CMO & Founder
Participates in a number of projects
Andrea Cau
Blockchain Developer
Participates in a number of projects
Stefano Salidu
UI/UX Developer
Participates in a number of projects
Martina Serusi
Community Manager
Participates in a number of projects

Advisors (3)

Marco Porcu
Participates in a number of projects
Arash Gholamzadeh Nasrabadi
Participates in a number of projects
Maurizio Atzori
Participates in a number of projects
HORIZONTAL
SQUARE
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Crypto Potential
Crypto badges. Simple. Rewarding. Transparent. Incentivizing achievements through dedicated crypto badges. Blockchain projects are evaluated and tested for specific parameters and awarded with badges according to their achievements and contribution. The badges stand for credibility and transparency and serve to incentivize qualified projects with QCP token. The Crypto-Potential community will have access to a selection of projects with verified information and their achievements. The mission is to empower projects to achieve more. The vision is to create a more transparent crypto space.
Upcoming
TruePlay
TruePlay is a B2B platform with a complex of software solutions for online gambling business. TruePlay is not a gambling-provider, casino operator or casino owner. TruePlay allows only licensed gambling companies to access to their software (Software-as-a-service). The team are aimed at developing online gambling and making it as legal and transparent as possible from any point of view, TruePlay team has strong partners and has more than 10 years’ experience in the gambling industry.Join TruePlay and take part in the development of the gambling industry.
Upcoming
DINO
In blockchain world, there is a huge knowledge gulf between non-computer professionals from different industries and smart contract development. The DINO Platform aims to address this problem with its proprietary technology, a cloud-based Graphical User Interface (GUI) smart contract Integrated Development Environment (IDE). Leveraging the technology of the DINO Platform, users can build their smart contracts with visualised logic flows. More than just a smart contract IDE, the DINO Platform is intended to build a smart contract ecosystem together with developers all over the world. In the smart contract market, developers may build and design smart contract templates and sell them to the general public.
Upcoming
Talao
Talao is the first Ethereum-based DAO for Talent, which introduces a unique way for users to own their data thanks to a secure digital vault storing their certificates on the blockchain. Talao provides a decentralized marketplace, governed by Talent, on which neither intermediaries nor commissions apply.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.